299 related articles for article (PubMed ID: 11888345)
1. Strategies for management of prostate cancer-related bone pain.
Pelger RC; Soerdjbalie-Maikoe V; Hamdy NA
Drugs Aging; 2001; 18(12):899-911. PubMed ID: 11888345
[TBL] [Abstract][Full Text] [Related]
2. The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates.
Hamdy NA; Papapoulos SE
Semin Nucl Med; 2001 Jan; 31(1):62-8. PubMed ID: 11200206
[TBL] [Abstract][Full Text] [Related]
3. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer in the late 1990s: hormone refractory disease options.
Moul JW; Lipo DR
Urol Nurs; 1999 Jun; 19(2):125-31; quiz 132-3. PubMed ID: 10633763
[TBL] [Abstract][Full Text] [Related]
5. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar N; Batraki M; Divgi CR
J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
[TBL] [Abstract][Full Text] [Related]
6. Radioisotopic treatment of bone pain from metastatic prostate cancer.
Sartor O
Curr Oncol Rep; 2003 May; 5(3):258-62. PubMed ID: 12667425
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates to prevent skeletal complications in men with metastatic prostate cancer.
Smith MR
J Urol; 2003 Dec; 170(6 Pt 2):S55-7; discussion S57-8. PubMed ID: 14610411
[TBL] [Abstract][Full Text] [Related]
8. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.
Logothetis CJ; Basch E; Molina A; Fizazi K; North SA; Chi KN; Jones RJ; Goodman OB; Mainwaring PN; Sternberg CN; Efstathiou E; Gagnon DD; Rothman M; Hao Y; Liu CS; Kheoh TS; Haqq CM; Scher HI; de Bono JS
Lancet Oncol; 2012 Dec; 13(12):1210-7. PubMed ID: 23142059
[TBL] [Abstract][Full Text] [Related]
9. External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate.
Benson RC; Hasan SM; Jones AG; Schlise S
J Urol; 1982 Jan; 127(1):69-71. PubMed ID: 6173495
[TBL] [Abstract][Full Text] [Related]
10. The systemic treatment of bone metastases.
Houston SJ; Rubens RD
Clin Orthop Relat Res; 1995 Mar; (312):95-104. PubMed ID: 7543393
[TBL] [Abstract][Full Text] [Related]
11. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
Heidenreich A; Hofmann R; Engelmann UH
J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
[TBL] [Abstract][Full Text] [Related]
12. First-line treatment of metastatic prostate cancer. Androgen suppression for symptomatic disease.
Prescrire Int; 2013 Feb; 22(135):48-51. PubMed ID: 23444510
[TBL] [Abstract][Full Text] [Related]
13. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
Rodrigues P; Hering F; Campagnari JC
Prostate Cancer Prostatic Dis; 2004; 7(4):350-4. PubMed ID: 15534620
[TBL] [Abstract][Full Text] [Related]
14. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
15. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
Sartor O; Reid RH; Hoskin PJ; Quick DP; Ell PJ; Coleman RE; Kotler JA; Freeman LM; Olivier P;
Urology; 2004 May; 63(5):940-5. PubMed ID: 15134985
[TBL] [Abstract][Full Text] [Related]
16. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
17. The use of radioisotopes for palliation of metastatic bone pain.
Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
[TBL] [Abstract][Full Text] [Related]
18. Natural history and treatment of bone complications in prostate cancer.
Saad F; Clarke N; Colombel M
Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
[TBL] [Abstract][Full Text] [Related]
19. Bone-directed treatments for prostate cancer.
Saad F
Hematol Oncol Clin North Am; 2006 Aug; 20(4):947-63. PubMed ID: 16861125
[TBL] [Abstract][Full Text] [Related]
20. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.
Tomblyn M
Cancer Control; 2012 Apr; 19(2):137-44. PubMed ID: 22487976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
